Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

HIV hyperimmune globulin or intravenous immune globulin inhibits response to an HIV vaccine.

Jelonek MT, Maskrey JL, Cummins LM, Arora Y, Steimer KS, White-Scharf M, Keller MA.

Biotechnol Appl Biochem. 1998 Apr;27(2):89-95.

PMID:
9569603
2.

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

Zolla-Pazner S, Lubeck M, Xu S, Burda S, Natuk RJ, Sinangil F, Steimer K, Gallo RC, Eichberg JW, Matthews T, Robert-Guroff M.

J Virol. 1998 Feb;72(2):1052-9.

3.

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

Fuller DH, Corb MM, Barnett S, Steimer K, Haynes JR.

Vaccine. 1997 Jun;15(8):924-6.

PMID:
9234549
4.

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.

Barnett SW, Rajasekar S, Legg H, Doe B, Fuller DH, Haynes JR, Walker CM, Steimer KS.

Vaccine. 1997 Jun;15(8):869-73.

PMID:
9234536
5.

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.

Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SC, Chanda PK, Nigida SM Jr, Markham PD, Zolla-Pazner S, Steimer K, Wade M, Reitz MS Jr, Arthur LO, Mizutani S, Davis A, Hung PP, Gallo RC, Eichberg J, Robert-Guroff M.

Nat Med. 1997 Jun;3(6):651-8.

PMID:
9176492
6.

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines.

Zolla-Pazner S, Alving C, Belshe R, Berman P, Burda S, Chigurupati P, Clements ML, Duliege AM, Excler JL, Hioe C, Kahn J, McElrath MJ, Sharpe S, Sinangil F, Steimer K, Walker MC, Wassef N, Xu S.

J Infect Dis. 1997 Apr;175(4):764-74.

PMID:
9086128
7.

HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells.

Banda NK, Tomczak JA, Shpall EJ, Sipple J, Akkina RK, Steimer KS, Hami L, Curiel TJ, Singer Harrison G.

Apoptosis. 1997;2(1):61-8.

PMID:
14646565
8.

Maternal monoclonal antibody to the V3 loop alters specificity of the response to a human immunodeficiency virus vaccine.

Jelonek MT, Maskrey JL, Steimer KS, Potts BJ, Higgins KW, Keller MA.

J Infect Dis. 1996 Oct;174(4):866-9.

PMID:
8843232
9.

Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees.

Murthy KK, Cobb EK, el-Amad Z, Ortega H, Hsueh FC, Satterfield W, Lee DR, Kalish ML, Haigwood NL, Kennedy RC, Steimer KS, Schultz A, Levy JA.

AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1341-8.

PMID:
8891113
10.

Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals.

Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Sheppard HW.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):95-104.

PMID:
8528739
11.

Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.

el-Amad Z, Murthy KK, Higgins K, Cobb EK, Haigwood NL, Levy JA, Steimer KS.

AIDS. 1995 Dec;9(12):1313-22.

PMID:
8605050
12.

Inhibition of the offspring anti-recombinant gp120 antibody response to a human immunodeficiency virus vaccine by maternal immunization in a murine model.

Jelonek MT, Maskrey JL, Steimer KS, Potts BJ, Higgins KW, Keller MA.

J Infect Dis. 1995 Aug;172(2):539-42.

PMID:
7622900
13.

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial.

Kahn JO, Steimer KS, Baenziger J, Duliege AM, Feinberg M, Elbeik T, Chesney M, Murcar N, Chernoff D, Sinangil F.

J Infect Dis. 1995 May;171(5):1343-7.

PMID:
7751714
14.
17.

Epitopes recognized by HIV-SF2 nef-specific CD4+ T-cell clones generated from HIV-1-uninfected donors.

Wentworth PA, Bathurst I, Feucht PH, Erlich HA, Steimer KS.

Vaccine. 1994 Feb;12(2):117-28.

PMID:
7511861
18.

Comparative immunogenicity of gp120-derived proteins and their induction of anti-V3 loop region antibodies.

Klinman DM, Steimer KS, Conover J.

J Acquir Immune Defic Syndr. 1992 Oct;5(10):1005-8.

PMID:
1280682
19.
21.

Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.

Haigwood NL, Misher L, Chin SM, Blair M, Planelles V, Scandella CJ, Steimer KS, Gardner MB, Yilma T, Hirsch VM, et al.

J Med Primatol. 1992 Feb-May;21(2-3):82-90.

PMID:
1433271
22.

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS.

J Virol. 1992 Jan;66(1):172-82.

23.

Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.

Steimer KS, Scandella CJ, Skiles PV, Haigwood NL.

Science. 1991 Oct 4;254(5028):105-8.

PMID:
1718036
24.

HeLa-LAV, an epithelial cell line stably infected with HIV-1.

Berg J, Doe B, Steimer KS, Wabl M.

J Virol Methods. 1991 Sep-Oct;34(2):173-80.

PMID:
1687144
25.

Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells.

Keller GA, Warner TG, Steimer KS, Hallewell RA.

Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7381-5.

26.

Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain.

Berg J, Lötscher E, Steimer KS, Capon DJ, Baenziger J, Jäck HM, Wabl M.

Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4723-7.

27.

Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals.

Krowka JF, Singh B, Stites DP, Maino VC, Narindray D, Hollander H, Jain S, Chen H, Blackwood L, Steimer KS.

Clin Immunol Immunopathol. 1991 Apr;59(1):53-64.

PMID:
1708316
28.

Importance of conformation on the neutralizing antibody response to HIV-1 gp120.

Steimer KS, Haigwood NL.

Biotechnol Ther. 1991;2(1-2):63-89.

PMID:
1726963
29.

HIV-1 neutralization directed to epitopes other than linear V3 determinants.

Steimer KS, Klasse PJ, McKeating JA.

AIDS. 1991;5 Suppl 2:S135-43. Review. No abstract available.

PMID:
1726953
30.

Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.

Abrignani S, Montagna D, Jeannet M, Wintsch J, Haigwood NL, Shuster JR, Steimer KS, Cruchaud A, Staehelin T.

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6136-40.

31.

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies.

Haigwood NL, Shuster JR, Moore GK, Lee H, Skiles PV, Higgins KW, Barr PJ, George-Nascimento C, Steimer KS.

AIDS Res Hum Retroviruses. 1990 Jul;6(7):855-69.

PMID:
2390335
32.

Anti-idiotypic antisera raised against monoclonal antibody specific for a p24 gag region epitope detects a common interspecies idiotype associated with anti-HIV responses.

Morrow WJ, Gaston I, Anderson T, Haigwood N, McGrath MS, Rosen J, Steimer KS.

Viral Immunol. 1990 Summer;3(2):99-109.

PMID:
1694432
33.

N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae.

Bathurst IC, Chester N, Gibson HL, Dennis AF, Steimer KS, Barr PJ.

J Virol. 1989 Jul;63(7):3176-9.

34.

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.

Evans LA, Thomson-Honnebier G, Steimer K, Paoletti E, Perkus ME, Hollander H, Levy JA.

AIDS. 1989 May;3(5):273-6.

PMID:
2548535
35.

Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Krowka JF, Stites DP, Jain S, Steimer KS, George-Nascimento C, Gyenes A, Barr PJ, Hollander H, Moss AR, Homsy JM, et al.

J Clin Invest. 1989 Apr;83(4):1198-203.

36.
37.
38.

Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae.

Barr PJ, Cousens LS, Lee-Ng CT, Medina-Selby A, Masiarz FR, Hallewell RA, Chamberlain SH, Bradley JD, Lee D, Steimer KS, et al.

J Biol Chem. 1988 Nov 5;263(31):16471-8.

39.

Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

Bedinger P, Moriarty A, von Borstel RC 2nd, Donovan NJ, Steimer KS, Littman DR.

Nature. 1988 Jul 14;334(6178):162-5.

PMID:
3260353
40.

Characterization of recombinant human epidermal growth factor produced in yeast.

George-Nascimento C, Gyenes A, Halloran SM, Merryweather J, Valenzuela P, Steimer KS, Masiarz FR, Randolph A.

Biochemistry. 1988 Jan 26;27(2):797-802.

PMID:
3280026
41.

In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures.

Busch MP, Rajagopalan MS, Gantz DM, Fu S, Steimer KS, Vyas GN.

Am J Clin Pathol. 1987 Dec;88(6):673-80.

PMID:
3318386
42.

Antibody to human immunodeficiency virus correlates with decreased T helper lymphocytes in asymptomatic individuals.

Weiser B, Burger H, Steimer K, Lifson J, Engleman E, Grimson R, Robinson WS.

J Med Virol. 1987 Jul;22(3):237-44.

PMID:
2957464
43.

Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae.

Barr PJ, Steimer KS, Sabin EA, Parkes D, George-Nascimento C, Stephans JC, Powers MA, Gyenes A, Van Nest GA, Miller ET, et al.

Vaccine. 1987 Jun;5(2):90-101.

PMID:
3300079
44.

Towards an AIDS vaccine: challenges and prospects.

Homsy J, Steimer K, Kaslow R.

Immunol Today. 1987;8(7-8):193-6. doi: 10.1016/0167-5699(87)90152-6.

PMID:
25290421
45.

Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EG.

Nature. 1986 Oct 23-29;323(6090):725-8.

PMID:
3095663
46.

Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria.

Steimer KS, Puma JP, Power MD, Powers MA, George-Nascimento C, Stephans JC, Levy JA, Sanchez-Pescador R, Luciw PA, Barr PJ, et al.

Virology. 1986 Apr 15;150(1):283-90.

PMID:
3006341
47.

Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.

Steimer KS, Higgins KW, Powers MA, Stephans JC, Gyenes A, George-Nascimento C, Luciw PA, Barr PJ, Hallewell RA, Sanchez-Pescador R.

J Virol. 1986 Apr;58(1):9-16.

49.

Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features.

Levy JA, Kaminsky LS, Morrow WJ, Steimer K, Luciw P, Dina D, Hoxie J, Oshiro L.

Ann Intern Med. 1985 Nov;103(5):694-9. Review.

PMID:
2996401
50.

Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library.

Hallewell RA, Masiarz FR, Najarian RC, Puma JP, Quiroga MR, Randolph A, Sanchez-Pescador R, Scandella CJ, Smith B, Steimer KS, et al.

Nucleic Acids Res. 1985 Mar 25;13(6):2017-34.

Supplemental Content

Loading ...
Support Center